Additional European Equity News

3i Group (III LN) - FY 2026 (GBP): Revenue 5.3bln (prev. 5.0bln Y/Y), NAV per share 3.03 (prev. 2.54 Y/Y), announces GBP 750mln share buyback programme. (3i Group)AstraZeneca (AZN LN) - Perioperative Imfinzi plus Imjudo and neoadjuvant EV showed a statistically significant and clinically meaningful improvement in event-free survival and a favourable trend for overall survival. (AstraZeneca)Aviva (AV/ LN) - Q1 Trading Update (GBP): General Insurance Premiums 3.4bln, +19% Y/Y. (Aviva)Burberry (BRBY LN) - Q4 2026 (GBP): Revenue 2.42bln (prev. 2.46bln Y/Y), Adj. Op. Profit 160mln (prev. 26mln Y/Y). Retail comp sales +5% (exp. +4.6%). CEO: “We’ve returned to profitable comparable sales growth, with a strong fourth quarter driven by momentum in Greater China and Americas. Our strategy is working and there are clear opportunities for further growth”. By Region: Returned to comparable sales growth from Q2, with sequential improvement throughout the year; particular strength in Greater China and Americas, both up double digit in Q4. FY27 Outlook: “In FY27 we expect to make further progress on our financial ambitions, including delivering revenue growth and margin expansion”. Wholesale is expected to grow by mid-single digit percentage in H1 FY27. Board Update: Chair Gerry Murphy has decided to retire, effective November 2026. Williams Jackson named as the replacement. (Burberry) The Burberry virtual presentation and earnings call is taking place today at 9:30 BSTIpsen (IPN FP) - Co. unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI, at the SCALE Symposium. Phase II data in glabellar (frown) lines to be featured as a late-breaking presentation at the SCALE Symposium. A broad Phase II and Phase III clinical program is advancing corabotase across multiple aesthetic and therapeutic indications. (Ipsen) ITV (ITV LN) - Q1 2026 (GBP): Revenue 877mln (prev. 875mln Y/Y), Media and Entertainment Revenue 477mln (prev. 489mln Y/Y), affirms FY26 guidance. (ITV)Land Securities (LAND LN) - FY 2026 (GBP): EPRA EPS 0.514 (prev. 0.503 Y/Y), Profit before tax 346mln (prev. 393mln Y/Y), EPRA EPS came in at the top end of guidance. CEO: "Over the past few years we have actively positioned Landsec for a higher inflation and higher interest rate world. Despite elevated geopolitical risks, we remain confident in the potential to deliver c. 5% CAGR in EPRA EPS between now and 2030." (Land Securities)Legal and General (LGEN LN) - FT reported "Will L&G be the City’s next domino to fall?", article cited comments from an insider, "Feels like we’re being dressed up for a sale.... they know they’ve got a structural problem and they are trying to throw everything at it."  (FT)National Grid (NG/ LN) - FY 2025/26 (GBP): Group Underlying Profit 5.68bln (prev. 5.22bln Y/Y), Underlying EPS 0.78 (prev. 0.73 Y/Y), Capital Investment 11.6bln (prev. 9.8bln). CEO: "We have delivered strong financial performance...setting the foundation to deliver compound annual growth rates across our five-year financial framework of around 10% asset growth and 8-10% underlying EPS growth." (National Grid)Siemens (SIE GY) - Co. acquires key businesses of MERMEC to strengthen its global rail technology portfolio. (Siemens)Watches of Switzerland (WOSG LN) - FY26 (GBP): Revenue 1.82bln, +13% Y/Y. Luxury Watch Revenue +13% Y/Y, Jewellery Revenue +18% Y/Y. Demand for our key luxury brands, particularly products on Registration of Interest lists, remains strong, outstripping supply in both the US and UK markets. FY27 Outlook: Revenue 5-10%, Adj. EBIT Margin 40-80bps expansion from FY26. (Watches of Switzerland)